Z-1677-2011
OSTEOMATRIX bone graft substitute. OMG10. Osteomatrix is provided sterile for single patient use
Biostructures, LLC / initiated 2011-01-31 / Terminated / root cause: labeling and UDI
Biostructures, LLC began a recall of OSTEOMATRIX bone graft substitute. OMG10. Osteomatrix is provided sterile for single patient use on . The reason FDA records is "The OsteoMatrix Synthetic Bone Graft Composite Instructions for Use document, P4G10A/Rev. 01 had language that was not consistent with the cleared indications". As of , the recall status on record is Terminated, and MDM tags the root cause as labeling and UDI.
Recall record
- Recall number
- Z-1677-2011
- Status
- Terminated
- Initiated
- Posted
- Terminated
- Recalling firm
- Biostructures, LLC
- Product
- OSTEOMATRIX bone graft substitute. OMG10. Osteomatrix is provided sterile for single patient use.
- Product code
- MQV Filler, Bone Void, Calcium Compound
- Reason for recall
- The OsteoMatrix Synthetic Bone Graft Composite Instructions for Use document, P4G10A/Rev. 01 had language that was not consistent with the cleared indications.
- Root cause tag
- labeling and UDI
- FDA root cause
- Other
- Action
- An email was sent on 06/15/2010 to the firm's distributors that had products with lot #0809D110 or lot #0307I208 in their possesion. The email was in regards to the distributors' OMG10 granule inventory. The distributors need to return all the recalled granule inventory to be swapped out for new inventory.
- Quantity in commerce
- 248 units
- Distribution
- Products were distributed to 6 consignees that were located in Michigan, Ohio, Maryland, California, Texas, and Utah.
- Product codes and lots
- OMG10/Lot # 0809D110 OMG10/Lot # 0307I208
FIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
